ELIDEL / hypersensitivity to pimecrolimus or any of the components of the cream
United States · event evidence
hypersensitivity to pimecrolimus or any of the components of the cream Listed
A history of hypersensitivity is stated as a contraindication.
Authority DailyMed, U.S. National Library of Medicine
Document ELIDEL (PIMECROLIMUS) CREAM [PHYSICIANS TOTAL CARE, INC.]
Jurisdiction United States
Version / revision 1
Document date Not recorded Coverage and use limitation This page presents source-linked records from the referenced label. Publication state: complete .
A search miss, unresolved section or unavailable label is not evidence that an event is unlisted or unexpected. Final expectedness assessment is context-dependent and remains outside an automated label comparison.
Verify material conclusions against the cited source document and apply appropriate professional judgement before formal use.
Source evidence ELIDEL ® (pimecrolimus) Cream 1% is contraindicated in individuals with a history of hypersensitivity to pimecrolimus or any of the components of the cream.
Section Not stated
Context A history of hypersensitivity is stated as a contraindication.
Frequency Not stated
Population / denominator Not stated Return to label evidence explorer